Lambda Theta Alpha serves thousands of hours each year to a variety of philanthropic causes and needs. In the effort to create a more united and bigger impact nationally, Lambda Theta Alpha selected a national philanthropy. In January of 2010, LTA became an official collegiate partner to St. Jude Children's Research Hospital, becoming the first individual Latino Greek organization to commit fully to the hospital's efforts. With this partnership, LTA provides our resources of community service and activism and more importantly, another direct link to the Hispanic community for St. Jude. LTA has pledged to raise awareness about childhood cancer and St. Jude in the Latin community, as well as fundraise for the hospital through a variety of events and programs.

Lambda Theta Alpha asks all to join in on the fight against childhood cancer. Your donations will make a difference in the lives of many children and their families.
 

About St. Judes

St. Jude Children's Research Hospital is internationally recognized for its pioneering work in finding cures and saving children with cancer and other catastrophic diseases. St. Jude is the first and only pediatric cancer center to be designated as a Comprehensive Cancer Center by the National Cancer Institute. Founded by late entertainer Danny Thomas and based in Memphis, TN, St. Jude freely shares its discoveries with scientific and medical communities around the world. St. Jude is the only pediatric cancer research center where families never pay for treatment not covered by insurance. No child is ever denied treatment because of the family's inability to pay.

Mission

The mission of St. Jude Children’s Research Hospital is to advance cures and means of prevention for pediatric catastrophic diseases through research and treatment. Consistent with the vision of founder Danny Thomas, no child is denied treatment based on race, religion, or a family's ability to pay. 

Vision

The vision of St Jude is to be the world leader in advancing the treatment and prevention of catastrophic diseases in children. This vision will be pursued by providing outstanding patient care; by conducting basic, translational and clinical research designed to elucidate biological mechanisms, understand disease pathogenesis, improve diagnosis, enhance treatment outcome, prevent diseases and minimize adverse consequences of treatment; and by educating health care and scientific research professionals. Through these efforts we seek to cure and enhance the quality of life for an increasing proportion of children who come to us for treatment, and by expanding and sharing knowledge, to advance treatment of children with catastrophic diseases worldwide, while developing strategies to prevent catastrophic diseases in children.